Skip to main content

Closed

SLN: Silence Therapeutics plc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-9396.6%

ROIC-82.7%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio9.83×

Silence Therapeutics plc

SLNNASDAQ Global Market·USD·Closed

Silence Therapeutics plc

SLNNASDAQ·USD·Closed

$10.49

−9.72%

$10.49

−$1.13 (9.72%)

52W Range

79thpctl

Volume

1.34×avg

Mkt Cap

495.48MUSD

P/E

-2.4TTM

Div Yield

–ann

52W Range

79thpctl

Volume

1.34×avg

Market Cap

495.48MUSD

P/E Ratio

-2.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings